About
ActiTrexx develops novel allogeneic regulatory T cell therapies aimed at restoring immune tolerance to treat autoimmune and autoinflammatory diseases such as GvHD and multiple sclerosis.
Explore ActiTrexx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.